China Universal Asset Management Co., Ltd. Lyell Immunopharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 48,855 shares of LYEL stock, worth $70,839. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,855
Previous 48,855
-0.0%
Holding current value
$70,839
Previous $109,000
0.92%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding LYEL
# of Institutions
128Shares Held
144MCall Options Held
0Put Options Held
5.9K-
Mwg Management Ltd. Washington, DC20.2MShares$29.2 Million33.29% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$21.9 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$21.9 Million19.02% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$19.4 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $359M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...